KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Change in Account Payables (2019 - 2025)

Hims & Hers Health's Change in Account Payables history spans 7 years, with the latest figure at -$45.8 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 629.0% year-over-year to -$45.8 million; the TTM value through Dec 2025 reached $30.3 million, down 30.69%, while the annual FY2025 figure was $30.3 million, 30.69% down from the prior year.
  • Change in Account Payables for Q4 2025 was -$45.8 million at Hims & Hers Health, down from $71.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $71.0 million in Q3 2025 and bottomed at -$45.8 million in Q4 2025.
  • The 5-year median for Change in Account Payables is $3.6 million (2021), against an average of $5.2 million.
  • The largest annual shift saw Change in Account Payables tumbled 738.41% in 2021 before it surged 1922.18% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at $3.5 million in 2021, then crashed by 117.17% to -$609000.0 in 2022, then soared by 579.97% to $2.9 million in 2023, then surged by 196.2% to $8.7 million in 2024, then plummeted by 629.0% to -$45.8 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Change in Account Payables are -$45.8 million (Q4 2025), $71.0 million (Q3 2025), and -$9.3 million (Q2 2025).